BBSRC Portfolio Analyser will be decommissioned at the end of 2025.
Other UKRI reporting services are available to you providing details of BBSRC investments: UKRI - What we have funded

Investigator / Supervisor details

NameDr Peter Maycox
Current InstitutionGlaxoSmithKline plc
Current DepartmentHarlow
Previous Institutions

Current Awards

No current BBSRC awards

Completed Awards

ReferenceTitleAward RoleValue £Type
00/A2/G/06977 Studies of oligodendrocyte development in zebrafish Co-Supervisor 38,404 Studentships
terms and conditions of use (opens in new window)
export PDF file